PAPOLA expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.694000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.222600E-01
Normal-vs-Stage2
7.563000E-01
Normal-vs-Stage3
5.172400E-01
Normal-vs-Stage4
2.223000E-01
Stage1-vs-Stage2
5.781400E-01
Stage1-vs-Stage3
5.927000E-01
Stage1-vs-Stage4
1.421790E-01
Stage2-vs-Stage3
3.051800E-01
Stage2-vs-Stage4
1.444410E-01
Stage3-vs-Stage4
1.091990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.312800E-01
Normal-vs-AfricanAmerican
9.530400E-01
Normal-vs-Asian
8.208200E-01
Caucasian-vs-AfricanAmerican
5.676000E-01
Caucasian-vs-Asian
2.406400E-01
AfricanAmerican-vs-Asian
8.272400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.962800E-01
Normal-vs-Female
8.553000E-01
Male-vs-Female
4.043800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.937800E-01
Normal-vs-Age(41-60Yrs)
3.892000E-01
Normal-vs-Age(61-80Yrs)
9.679400E-01
Normal-vs-Age(81-100Yrs)
9.931000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.891800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.631400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.875800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.116500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.060950E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.482000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.055600E-01
Normal-vs-Daily Drinker
9.553200E-01
Normal-vs-Weekly Drinker
8.167600E-01
Normal-vs-Occasional Drinker
2.836000E-01
Normal-vs-Social Drinker
7.271800E-01
Non Drinker-vs-Daily Drinker
5.290600E-01
Non Drinker-vs-Weekly Drinker
9.710600E-01
Non Drinker-vs-Occasional Drinker
1.939770E-02
Non Drinker-vs-Social Drinker
2.492400E-01
Daily Drinker-vs-Weekly Drinker
5.974200E-01
Daily Drinker-vs-Occasional Drinker
9.682400E-02
Daily Drinker-vs-Social Drinker
5.541000E-01
Weekly Drinker-vs-Occasional Drinker
5.260100E-02
Weekly Drinker-vs-Social Drinker
3.509000E-01
Occasional Drinker-vs-Social Drinker
4.212600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.813990E-01
Normal-vs-Grade 2
4.569900E-02
Normal-vs-Grade 3
5.211600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.893200E-01
Grade 1-vs-Grade 3
6.406600E-01
Grade 1-vs-Grade 4
1.813990E-01
Grade 2-vs-Grade 3
7.583000E-01
Grade 2-vs-Grade 4
4.569900E-02
Grade 3-vs-Grade 4
5.211600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.925600E-01
Normal-vs-NonDiabetic
8.515000E-01
Diabetic-vs-NonDiabetic
8.474800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.984600E-01
Normal-vs-NoPancreatitis
7.853200E-01
Pancreatitis-vs-NoPancreatitis
9.314000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.389200E-01
Normal-vs-N1
6.936800E-01
N0-vs-N1
3.116200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.087800E-02
Normal-vs-TP53-NonMutant
9.232600E-01
TP53-Mutant-vs-TP53-NonMutant
6.435700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
